Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo

BACKGROUND: Chemotherapy with gemcitabine and nab-paclitaxel (gemcitabine/nab-paclitaxel) is recommended for unresectable pancreatic cancer. However, the therapeutic efficacy is attenuated by the antitumor agent-induced activation of nuclear factor-κB (NF-κB). Thalidomide inhibits NF-κB activation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Nobuhiro, Shirai, Yoshihiro, Uwagawa, Tadashi, Horiuchi, Takashi, Sugano, Hiroshi, Haruki, Koichiro, Shiba, Hiroaki, Ohashi, Toya, Yanaga, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884664/
https://www.ncbi.nlm.nih.gov/pubmed/29644009
http://dx.doi.org/10.18632/oncotarget.24608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884664/
https://www.ncbi.nlm.nih.gov/pubmed/29644009
http://dx.doi.org/10.18632/oncotarget.24608

Ejemplares similares